This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yousef, G. M. Articles by Diamandis, E. P. Search for Related Content PubMed PubMed Citation Articles by Yousef, G. M. Articles by Diamandis, E. P.

Prostase/KLK-L1 Is a New Member of the Human Kallikrein Gene Family, Is Expressed in Prostate and Breast Tissues, and Is Hormonally Regulated

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5 [G. M. Y., C. V. O., L-Y. L., M. H. B., E. P. D.]; and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5 [G. M. Y., C. V. O., L-Y. L., E. P. D.], Canada

By using the positional candidate gene approach, we were able to identify a novel serine protease gene that maps to chromosome 19q13.3–q13.4. Screening of expressed sequence tags allowed us to establish the expression of the gene and delineate its genomic organization (GenBank accession no. AF135023). We named this gene KLK-L1. Another group, by using a subtraction hybridization method, cloned the same gene and named it prostase (GenBank accession nos. AF113140 and AF113141). Here, we describe the precise mapping and localization of the prostase/KLK-L1 gene between the known genes KLK2 (human glandular kallikrein) and zyme (also known as protease M/neurosin). The direction of transcription of prostase/KLK-L1 is the same as that of zyme but opposite to that of KLK2 and prostate-specific antigen genes. Contrary to the initial impression, prostase/KLK-L1 is expressed at high levels not only in prostate tissue but also in testis, mammary gland, adrenals, uterus, thyroid, and salivary glands. We have further demonstrated with in vitro experiments with the breast carcinoma cell line BT-474 that this gene is expressed and that its expression is up-regulated by androgens and progestins. On the basis of information on other genes that are localized in the same region (prostate-specific antigen, KLK2, zyme, and normal epithelial cell specific-1 gene), we speculate that prostase/KLK-L1 may be involved in the pathogenesis and/or progression of prostate, breast, and possibly other malignancies.

This article has been cited by other articles:

				J. Lai, S. A. Myers, M. G. Lawrence, D. M. Odorico, and J. A. Clements Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer Mol. Cancer Res., January 1, 2009; 7(1): 129 - 141. [Abstract] [Full Text] [PDF]

				A. J. Ramsay, Y. Dong, M. L. Hunt, M. Linn, H. Samaratunga, J. A. Clements, and J. D. Hooper Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs): KLK4 AND PAR-2 ARE CO-EXPRESSED DURING PROSTATE CANCER PROGRESSION J. Biol. Chem., May 2, 2008; 283(18): 12293 - 12304. [Abstract] [Full Text] [PDF]

				T. I. Klokk, A. Kilander, Z. Xi, H. Waehre, B. Risberg, H. E. Danielsen, and F. Saatcioglu Kallikrein 4 Is a Proliferative Factor that Is Overexpressed in Prostate Cancer Cancer Res., June 1, 2007; 67(11): 5221 - 5230. [Abstract] [Full Text] [PDF]

				K.-i. Kiyomiya, M.-S. Lee, I-C. Tseng, H. Zuo, R. J. Barndt, M. D. Johnson, R. B. Dickson, and C.-Y. Lin Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells Am J Physiol Cell Physiol, July 1, 2006; 291(1): C40 - C49. [Abstract] [Full Text] [PDF]

				Y Dong, L T Bui, D M Odorico, O L Tan, S A Myers, H Samaratunga, R A Gardiner, and J A Clements Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms Endocr. Relat. Cancer, December 1, 2005; 12(4): 875 - 889. [Abstract] [Full Text] [PDF]

				C. V. Obiezu, S. J.C. Shan, A. Soosaipillai, L.-Y. Luo, L. Grass, G. Sotiropoulou, C. D. Petraki, P. A. Papanastasiou, M. A. Levesque, and E. P. Diamandis Human Kallikrein 4: Quantitative Study in Tissues and Evidence for Its Secretion into Biological Fluids Clin. Chem., August 1, 2005; 51(8): 1432 - 1442. [Abstract] [Full Text] [PDF]

				C. A. Borgono, I. P. Michael, and E. P. Diamandis Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280. [Abstract] [Full Text] [PDF]

				Z. Xi, T. I. Klokk, K. Korkmaz, P. Kurys, C. Elbi, B. Risberg, H. Danielsen, M. Loda, and F. Saatcioglu Kallikrein 4 is a Predominantly Nuclear Protein and Is Overexpressed in Prostate Cancer Cancer Res., April 1, 2004; 64(7): 2365 - 2370. [Abstract] [Full Text] [PDF]

				S. P. Balk, Y.-J. Ko, and G. J. Bubley Biology of Prostate-Specific Antigen J. Clin. Oncol., January 15, 2003; 21(2): 383 - 391. [Abstract] [Full Text] [PDF]

				C. D. Petraki, V. N. Karavana, L.-Y. Luo, and E. P. Diamandis Human Kallikrein 10 Expression in Normal Tissues by Immunohistochemistry J. Histochem. Cytochem., September 1, 2002; 50(9): 1247 - 1261. [Abstract] [Full Text] [PDF]

				C. V. Obiezu, A. Soosaipillai, K. Jung, C. Stephan, A. Scorilas, D. H. C. Howarth, and E. P. Diamandis Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and Immunohistochemistry Clin. Chem., August 1, 2002; 48(8): 1232 - 1240. [Abstract] [Full Text] [PDF]

				J. A. Hural, R. S. Friedman, A. McNabb, S. S. Steen, R. A. Henderson, and M. Kalos Identification of Naturally Processed CD4 T Cell Epitopes from the Prostate-Specific Antigen Kallikrein 4 Using Peptide-Based In Vitro Stimulation J. Immunol., July 1, 2002; 169(1): 557 - 565. [Abstract] [Full Text] [PDF]

				X. Wu, A. Blanck, G. Norstedt, L. Sahlin, and A. Flores-Morales Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium Mol. Hum. Reprod., March 1, 2002; 8(3): 246 - 254. [Abstract] [Full Text] [PDF]

				H. Aksoy, F. Akcay, Z. Umudum, A. K. Yildirim, and R. Memisogullari Changes of PSA Concentrations in Serum and Saliva of Healthy Women during the Menstrual Cycle Ann. Clin. Lab. Sci., January 1, 2002; 32(1): 31 - 36. [Abstract] [Full Text] [PDF]

				H. Matsui and T. Takahashi Mouse Testicular Leydig Cells Express Klk21, a Tissue Kallikrein That Cleaves Fibronectin and IGF-Binding Protein-3 Endocrinology, November 1, 2001; 142(11): 4918 - 4929. [Abstract] [Full Text] [PDF]

				G. M. Yousef, L. G. Kyriakopoulou, A. Scorilas, S. Fracchioli, B. Ghiringhello, M. Zarghooni, A. Chang, M. Diamandis, G. Giardina, W. J. Hartwick, et al. Quantitative Expression of the Human Kallikrein Gene 9 (KLK9) in Ovarian Cancer: A New Independent and Favorable Prognostic Marker Cancer Res., November 1, 2001; 61(21): 7811 - 7818. [Abstract] [Full Text] [PDF]

				Y. Dong, A. Kaushal, L. Bui, S. Chu, P. J. Fuller, J. Nicklin, H. Samaratunga, and J. A. Clements Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas Clin. Cancer Res., August 1, 2001; 7(8): 2363 - 2371. [Abstract] [Full Text] [PDF]

				C. V. Obiezu, A. Scorilas, D. Katsaros, M. Massobrio, G. M. Yousef, S. Fracchioli, I. A. Rigault de la Longrais, R. Arisio, and E. P. Diamandis Higher Human Kallikrein Gene 4 (KLK4) Expression Indicates Poor Prognosis of Ovarian Cancer Patients Clin. Cancer Res., August 1, 2001; 7(8): 2380 - 2386. [Abstract] [Full Text] [PDF]

				G. M. Yousef and E. P. Diamandis The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease Endocr. Rev., April 1, 2001; 22(2): 184 - 204. [Abstract] [Full Text]

				G. M. Yousef, A. Magklara, A. Chang, K. Jung, D. Katsaros, and E. P. Diamandis Cloning of a New Member of the Human Kallikrein Gene Family, KLK14, Which Is Down-Regulated in Different Malignancies Cancer Res., April 1, 2001; 61(8): 3425 - 3431. [Abstract] [Full Text]

				D. E. H. Afar, I. Vivanco, R. S. Hubert, J. Kuo, E. Chen, D. C. Saffran, A. B. Raitano, and A. Jakobovits Catalytic Cleavage of the Androgen-regulated TMPRSS2 Protease Results in Its Secretion by Prostate and Prostate Cancer Epithelia Cancer Res., February 1, 2001; 61(4): 1686 - 1692. [Abstract] [Full Text]

				E. P. Diamandis, G. M. Yousef, J. Clements, L. K. Ashworth, S. Yoshida, T. Egelrud, P. S. Nelson, S. Shiosaka, S. Little, H. Lilja, et al. New Nomenclature for the Human Tissue Kallikrein Gene Family Clin. Chem., November 1, 2000; 46(11): 1855 - 1858. [Full Text] [PDF]

				E. P. Diamandis Prostate-specific Antigen: A Cancer Fighter and a Valuable Messenger? Clin. Chem., July 1, 2000; 46(7): 896 - 900. [Abstract] [Full Text] [PDF]

				G. M. Yousef, A. Chang, and E. P. Diamandis Identification and Characterization of KLK-L4, a New Kallikrein-like Gene That Appears to be Down-regulated in Breast Cancer Tissues J. Biol. Chem., April 14, 2000; 275(16): 11891 - 11898. [Abstract] [Full Text] [PDF]

				T. J. Harvey, J. D. Hooper, S. A. Myers, S.-A. Stephenson, L. K. Ashworth, and J. A. Clements Tissue-specific Expression Patterns and Fine Mapping of the Human Kallikrein (KLK) Locus on Proximal 19q13.4 J. Biol. Chem., November 22, 2000; 275(48): 37397 - 37406. [Abstract] [Full Text] [PDF]

				G. M. Yousef, A. Scorilas, K. Jung, L. K. Ashworth, and E. P. Diamandis Molecular Cloning of the Human Kallikrein 15 Gene (KLK15). UP-REGULATION IN PROSTATE CANCER J. Biol. Chem., January 5, 2001; 276(1): 53 - 61. [Abstract] [Full Text] [PDF]